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 The ascomycete fungus Fusarium graminearum is the most common 
pathogen of Fusarium head blight (FHB), a devastating disease for major cereal 
crops worldwide. FHB causes significant crop losses by reducing grain yield and 
quality as well as contaminating cereals with trichothecenes and zearalenone 
(ZEA) that pose a serious threat to animal health and food safety. ZEA is a 
causative agent of hyperestrogenic syndrome in mammals and can result in 
reproductive disorders in farm animals. In F. graminearum, the ZEA biosynthetic 
cluster is composed of four genes, PKS4, PKS13, ZEB1, and ZEB2, which encode a 
reducing polyketide synthase, a nonreducing polyketide synthase, an isoamyl 
alcohol oxidase, and a transcription factor, respectively. Although it is known that 
ZEB2 primarily acts as a regulator of ZEA biosynthetic cluster genes, the 
 ２ 
mechanism underlying this regulation remains undetermined. In this study, two 
isoforms (ZEB2L and ZEB2S) from the ZEB2 gene in F. graminearum were 
characterized. It was revealed that ZEB2L contains a basic leucine zipper (bZIP) 
DNA-binding domain at the N-terminus, whereas ZEB2S is an N-terminally 
truncated form of ZEB2L that lacks the bZIP domain. Interestingly, ZEA triggered 
the induction of both ZEB2L and ZEB2S transcription. In ZEA producing condition, 
the expression of ZEB2S transcripts via alternative promoter usage was directly or 
indirectly initiated by ZEA. Physical interaction between ZEB2L and ZEB2L as 
well as between ZEB2L and ZEB2S was observed in the nucleus. The ZEB2S-
ZEB2S interaction was detected in both the cytosol and the nucleus. ZEB2L-
ZEB2L oligomers activated ZEA biosynthetic cluster genes, including ZEB2L. 
ZEB2S inhibited ZEB2L transcription by forming ZEB2L-ZEB2S heterodimers, 
which reduced the DNA-binding activity of ZEB2L. This study provides insight 
into the autoregulation of ZEB2 expression by alternative promoter usage and a 
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The ascomycete fungus Fusarium graminearum is the causal agent of 
Fusarium head blight (FHB), a devastating disease for major cereal crops 
worldwide. FHB causes significant yield loss, but also reduces the quality and 
feeding value of the grain. The fungi that cause FHB may contaminate cereals with 
trichothecenes and zearalenone (ZEA) mycotoxins that pose a serious threat to 
animal health and food safety, thus dramatically lowering the market value of the 
crops.  
Zearalenone (ZEA, 6-[10-hydroxy-6-oxo-trans-1-undecenyl]-β-
resorcyclic acid lactone) is a polyketide mycotoxin produced by several Fusarium 
species, including F. graminearum, F. culmorum, F. equiseti, and F. crookwellense 
(Zinedine et al., 2007; Desjardins, 2006; Marasas et al., 1984). ZEA induces 
hyperestrogenic effects in mammals, which may result in reproductive disorders in 
farm and laboratory animals (Desjardins, 2006). ZEA commonly coexists with the 
trichothecene mycotoxin deoxynivalenol in cereal crops infected with F. 
graminearum, which is the primary causal agent of Fusarium head blight of small-
grain cereals worldwide (Desjardins, 2006; Marasas et al., 1984). ZEA is also a 
regular contaminant of foodstuffs, including cornmeal, corn flakes, corn porridge, 
and beer; therefore, it is a threat to human health (Marasas et al., 1984). 
Additionally, a synthetic commercial formulation of the reduced form of ZEA 
(zeranol) increases estrogenic activity and has been used to increase cattle growth 
in several regions throughout the world (Zhong et al., 2011).  
 ZEA is synthesized by the head-to-tail condensation of acetate units via the 
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acetate-malonyl-coenzyme A (CoA) enzyme system through a polyketide pathway    
(Steele et al., 1974; Mirocha et al., 1978). The ZEA biosynthetic cluster genes 
PKS4, PKS13, ZEB1, and ZEB2 encode a reducing polyketide synthase, a 
nonreducing polyketide synthase, an isoamyl alcohol oxidase, and a basic leucine 
zipper (bZIP) transcription factor (TF), respectively (Kim et al., 2005b; Gaffoor 
and Trail, 2006; Lysøe et al., 2006). The ZEA biosynthetic pathway is initiated by 
PKS4, which catalyzes the condensation of carbons from one acetyl-CoA and five 
malonyl-CoA molecules, resulting in the formation of an alkene. After this alkene 
is delivered to PKS13, the synthase continues to extend the ZEA chain by adding 
three malonyl-CoA molecules. Then, the unreduced ketones undergo 
intramolecular aromatic reactions, causing the formation of an aromatic ring and a 
macrolide ring structure containing a lactone bond (Gaffoor and Trail, 2006). The 
conversion of β-zearalenol to ZEA is catalyzed by ZEB1, with ZEB2 acting as a 
potential transcriptional activator of genes that regulate ZEA biosynthesis (Kim et 
al., 2005b). 
 Although ZEB2 primarily acts as a regulator of ZEA biosynthetic cluster 
genes, the mechanism underlying this regulation remains undetermined. In a 
previous study, two potential ZEB2 transcripts were found to be expressed under 
ZEA-producing conditions; however, the identities and functions of these 
transcripts remained unknown (Kim et al., 2005b). Because these two ZEB2 
transcripts had different expression patterns with distinct maximal expression and 
termination times, I hypothesized that they are formed by alternative transcription 
events and that their protein products have different effects on ZEA production. 
Alternative splicing is a well-described biochemical process in which multiple 
 10 
protein isoforms are formed from a single gene, thereby increasing proteomic and 
functional diversity in eukaryotes (Matlin et al., 2005). Alternative splicing is 
tightly linked to other processes that lead to the expression of different mRNAs 
from one gene, such as transcription initiation using alternative promoters and 
alternative polyadenylation (Artamonova and Gelfand, 2007). In this study, I 
determined the identities of these two ZEB2 transcripts, analyzed the effects of 
their protein products on ZEA biosynthesis, and identified their protein-interacting 
partners. Overall, this study provides important insights into the mechanisms that 
regulate ZEA biosynthesis. 
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MATERIALS AND METHODS 
I. Fungal strains and culture conditions 
 The F. graminearum wild-type strain Z-3639 (Bowden and Leslie, 1999) 
and mutants derived from this strain were maintained according to the Fusarium 
laboratory manual (Leslie and Summerell, 2006) and were stored in 20% (v/v) 
glycerol at -70 °C. The ZEA-deficient mutants Δzeb2, Δpks4 and Δpks13 were 
obtained from a previous experiment (Kim et al., 2005b). All strains used in this 
study are listed in Table 1. For genomic DNA isolation, fungal cultures grown in 
liquid complete medium (CM) for 5 days at 25 C were harvested and lyophilized. 
The genomic DNA isolation procedures were performed as previously described 
(Leslie and Summerell, 2006). For total RNA and protein extraction and for ZEA 
production analysis, wild-type and mutant strains were grown in 25 ml of CM or 
SG liquid medium (Bacon et al., 1977). 
 
II. cDNA library construction 
Total RNA was isolated from 6-day-old wild-type cultures grown in SG 
liquid medium using TRIzol (Invitrogen, Carlsbad, CA, USA). Then, 250 μg of 
total RNA was further purified using the Oligotex mRNA kit (Qiagen, Valencia, 
CA, USA). Approximately 0.5 μg of mRNA was reverse-transcribed using the 
EasyClone cDNA library construction kit (Dualsystems Biotech, Schlieren, 
Switzerland). The mRNA sample was purified using the NucleoSpin Extract II kit 
(Macherey-Nagel, Düren, Germany). SfiI-digested double-stranded cDNA was 





Table 1. F. graminearum strains used in this study. 
Strain Description and genotype Reference or parents 
Z-3639 F. graminearum wild-type strain Bowden and Leslie, 
1999 
Δmat1 Tester strain for outcross: Δmat1-1-1::Gen
R 
 Lee et al., 2003 
Δzeb2 Deletion mutant of the ZEB2 gene: Δzeb2::Gen
R 
 Kim et al., 2005b 
Δpks4 Deletion mutant of the PKS4 gene: Δpks4::Gen
R
 Kim et al., 2005b 
Δpks13 Deletion mutant of the PKS13 gene: Δpks13::Gen
R
 Kim et al., 2005b 






Hong et al., 2010 






Son et al., 2011a 














FAZ005 Strain expressing ZEB2S-Flag in Z-3639: PZEB2S-ZEB2S-Flag-TZEB2-Hyg
R
 This study 







FAZ001C Complemented strain overexpressing ZEB2L-HA in the deletion mutant for  
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FAZ001 × FAZ002C 














FAZ009 Complemented strain overexpressing ZEB2LM-HA in the deletion mutant: 
Δzeb2::Gen
R




FAZ010 Complemented strain overexpressing ZEB2LM-Flag in the deletion mutant: 
Δzeb2::Gen
R




FAZ011 Complemented strain overexpressing ZEB2SM-Flag in the deletion mutant: 
Δzeb2::Gen
R































FAZ002C × FAZ008 
FAZ014 
(L/LM) 









FAZ001C × FAZ010 
FAZ015 
(S/LM) 









FAZ002C × FAZ009 
FAZ016 
(L/SM) 









FAZ001C × FAZ011 






















FAZ018 × Δmat1 




















FAZ017 × mat1r 








FAZ018 × mat1g 
FAZ024 Complemented strain overexpressing ZEB2L-YFP
N









FAZ024C Complemented strain overexpressing ZEB2L-YFP
N










FAZ024 × Δmat1 
FAZ025 Complemented strain overexpressing ZEB2L-YFP
C









FAZ026 Complemented strain overexpressing ZEB2S-YFP
N









FAZ026C Complemented strain overexpressing ZEB2S-YFP
N










FAZ026 × Δmat1 
FAZ027 Complemented strain overexpressing ZEB2S-YFP
C









FAZ028 Complemented strain overexpressing ZEB2LM-YFP
N










FAZ028C Complemented strain overexpressing ZEB2LM-YFP
N










FAZ028 × Δmat1 

















FAZ024C × FAZ025 

















FAZ024C × FAZ027 

















FAZ026C × FAZ027 

















FAZ028C × FAZ025 

















FAZ028C × FAZ027 
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column (Clontech, Palo Alto, CA, USA) and was directly cloned into the pPR3-N 
library vector. The ligation mixture was transformed into DH10B Electromax cells 
(Invitrogen) for amplification of the cDNA library. 
 
III. ZEB2 transcript identification 
 The cDNA library described above was used for cDNA sequencing 
analysis. Primary PCR was performed with the Anchor-5N/PZ3-1 and Anchor-
3N/PZ5-1 primer pairs. Diluted PCR products were reamplified under the same 
conditions with both anchor primers and the nested primers PZ5-2 and PZ3-2. The 
major bands resolved by agarose gel electrophoresis were gel-purified, cloned into 
the pGEM-T easy vector (Promega, Madison, WI, USA), and sequenced. The PCR 
primers (Table 2) used in this study were synthesized by the Bionics 
oligonucleotide synthesis facility (Seoul, Korea). DNA sequencing was performed 
by Macrogen Inc. (Seoul, Korea). 
 For Northern blot analyses, DNA probes specific to the N-terminus 
(PZ019-5/PZ189-3 for probe 1 and PZ187-5/PZ453-3 for probe 2) or C-terminus of 
ZEB2 (PZ577-5/PZ790-3 for probe 3 and PZ919-5/PZ1086-3 for probe 4) were 
generated. Exogenous ZEA can induce ZEA biosynthetic cluster genes; therefore, 
SG liquid medium was supplemented with 1 ppm ZEA to increase the band 
intensity for Northern blot analyses (Lee et al., 2011a). Total RNA was extracted 
from wild-type cultures grown in SG liquid medium containing or lacking 1 ppm 
ZEA. Gel electrophoresis, gel blotting, and hybridization with 
32
P-labeled probes 
were performed according  to standard  procedures (Green and Sambrook, 2012). 
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Table 2. Primers used in this study. 
Primer Sequence (5'-3') Purpose 
Anchor-5N GTCGAAAATTCAAGACAAGG cDNA sequencing 
Anchor-3N AAGCGTGACATAACTAATTAC cDNA sequencing 
PZ5-1 ATGAGTCGTATTCTCAAGGTTATTCAGG 
cDNA sequencing (position bp 574 of 
ZEB2L) 
PZ5-2/ PZ577-5 AGTCGTATTCTCAAGGTTATTCAGGATG 
cDNA sequencing and amplification of 
Northern blot probe c 
PZ3-1 GGCGTAGATGGCTTCGGCTGATTTAGATAT cDNA sequencing 
PZ3-2/ PZ790-3 ATATCTCTTGTTGGTAATCATGTGCTTCA 
cDNA sequencing and amplification of 
Northern blot probe c 
PZ019-5 ATGCAATCTACCGAGTCGTTCCAT Amplification of Northern blot probe a 
PZ189-3 ATTCGACGTTTGGCATTGGTTGTTGAC Amplification of Northern blot probe a 
PZ187-5 AATTGGACCAGCCACGCACCCACAGAT Amplification of Northern blot probe b 
PZ453-3 TGAGCTATGATCGCCGATAGAAAGGCCT Amplification of Northern blot probe b 
PZ919-5 ATTGAGAACCATCTCCGACACGAACAG Amplification of Northern blot probe d 
PZ1089-3 TCAATTTTGCGACATACGGGAGGCTTGTAG Amplification of Northern blot probe d   
PEFp-5 ApaI gatcgggcccGACTCACTATAGAATTCCGGTACCTATA 
Amplification of overexpressed 
promoter (PEF1α) 
PEFp-3 SpeI gatcactagtTTTGAAGATTGGGTTCCTTTTGTG Amplification of overexpressed 
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promoter (PEF1α) 
PZLp-5 ApaI gatcgggcccAGTGCCAGGCTGTTGTCTACCATGTAT 
Amplification of native ZEB2L promoter 
(PZEB2L, -1166 to -1) 
PZLp-3 SpeI gatcactagtTTAAGCTGAATTAAGGTCACGGCCGTT 
Amplification of native ZEB2L promoter 
(PZEB2L, -1166 to -1) 
PZSp-5 ApaI gatcgggcccAACGGCCGTGACCTTAATTCAGCTTAA 
Amplification of native ZEB2S promoter 
(PZEB2S, -27 to +604) 
PZSp-3 SpeI gatcactagtGTCGCGGAGGTCTTGGTTGCACAGATTAT 
Amplification of native ZEB2S 
promoter (PZEB2S, -27 to +604) 
PZLO-5 SpeI gatcactagtATGACATTGGTTGACAATATGCAAT 
Amplification of ZEB2L coding 
sequence 
PZSO-5 SpeI gatcactagtATGGTGCCCGAGGAGAAAATGAGTCGT 
Amplification of ZEB2S coding 
sequence 
PZLO-3 BamHI gatcggatccATTTTGCGACATACGGGAGGCTTGTAG Amplification of ZEB2 coding sequence 
PZLO-5 EcoRI gatcgaattcATGACATTGGTTGACAATATGCAAT Insertion of ZEB2L into pET28a 
PZSO-5 EcoRI gatcgaattcATGGTGCCCGAGGAGAAAATGAGTCGT Insertion of ZEB2S into pET28a 
PZLO-3 XhoI gatcctcgagATTTTGCGACATACGGGAGGCTTGTAG Insertion of ZEB2 into pET28a 
PZt-5 HindIII gatcaagcttTGATGTAACTATATTGATGGACATGGG 
Insertion of ZEB2 terminator into 
pGZT001 






Point mutation of two internal start 





Point mutation of two internal start 




























Fusion of Flag to ZEB2 
Gly Link-5 GATCCGGGGGAGGCGGGGGTG Fusion of glycine linker to ZEB2 
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Gly Link-3 GATCCACCCCCGCCTCCCCCG Fusion of glycine linker to ZEB2 
PGFP-5 BamHI gatcggatccATGGTGAGCAAGGGCGAGGAGCTGT Amplification of the GFP reporter gene 









Amplification of the N-terminal YFP 




Amplification of the N-terminal YFP 




Amplification of the C-terminal YFP 




Amplification of the C-terminal YFP 













Yeast two-hybrid assay (aa 129 of 
ZEB2L) 
PY173-5 SfiI aacgcagagaggccattacggccCGACAGCACGATAATCTGTGCAA Yeast two-hybrid assay (aa 173 of 
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CCAAGACC ZEB2L) 
PY172-3 HindIII  gatcaagcttAGTTGGAAGACTCCCTTCTGTCGATCCA 
Yeast two-hybrid assay (aa 172 of 
ZEB2L) 
PY186-5 HindIII gatcaagcttATGGTGCCCGAGGAGAAAATGAGTCGTATTCT 
Yeast two-hybrid assay (aa 186 of 
ZEB2L) 
PY185-3 HindIII  gatcaagcttGTCGCGGAGGTCTTGGTTGCACAGATTAT 
Yeast two-hybrid assay (aa 185 of 
ZEB2L) 
PY192-5 HindIII gatcaagcttATGAGTCGTATTCTCAAGGTTATTCAGG 










Yeast two-hybrid assay (aa 192 of 
ZEB2L) 
PY207-5 SfiI aacgcagagaggccattacggccATGGATTCATTCATGACTGAGT 










Yeast two-hybrid assay (aa 337 of 
ZEB2L) 
PBTUp-5 AGGAAGCTACTGATCTCCAGGA Amplification of the β-tubulin promoter 
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(-641 to -1) 
PBTUp-3 ATTGACGGCTGTAGATGTAATG 
Amplification of the β-tubulin promoter 
(-641 to -1) 
PPKS4p1-5 CGTATCATGGAGAGAATC 
Amplification of the PKS4 promoter (-
711 to -389) 
PPKS4p1-3 CGCTCTTCAGAAGGTCCCAGA 
Amplification of the PKS4 promoter (-
711 to -389) 
PPKS4p2-5 GAAAAGGTGAGCAGCAATAAGA 
Amplification of the PKS4 promoter (-
388 to -1) 
PPKS4p2-3 TCGCTCATGGAGGATCCAACA 
Amplification of the PKS4 promoter (-
388 to -1) 
PPKS13p1-5 GCCTCATATTTCTTGGATTCATCA 
Amplification of the PKS13 promoter (-
777 to -411) 
PPKS13p1-3 TGTCAGATTTACAGTCAGCGTAGC 
Amplification of the PKS13 promoter (-
777 to -411) 
PPKS13p2-5 TGTTCCGCTTCTAAGCACATACA 
Amplification of the PKS13 promoter (-
410 to +40) 
PPKS13p2-3 GATCTCCGAAGAGAAGGATTGTTTTC 
Amplification of the PKS13 promoter (-
410 to +40) 
PZEB1p1-5 AAACATCAAGCTCTGGGAAG Amplification of the ZEB1 promoter (-
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1124 to -558) 
PZEB1p1-3 ACATTTGTTCCGTTTCTCCTCA 
Amplification of the ZEB1 promoter (-
1124 to -558) 
PZEB1p2-5 TGAGGAGAAACGGAACAAATGT 
Amplification of the ZEB1 promoter (-
580 to -298) 
PZEB1p2-3 ACGAACGTAAGCGTTATGGCT 
Amplification of the ZEB1 promoter (-
580 to -298) 
PZEB1p3-5 TTCCTCTAGATACTTCATTGTGCTCTTA 
Amplification of the ZEB1 promoter (-
298 to +31) 
PZEB1p3-3 CGGGTAAATATTTTGACGGCG 
Amplification of the ZEB1 promoter (-
298 to +31) 
PZEB2Lp1-5 CAGGCTGTTGTCTACCATGT 
Amplification of the ZEB2 promoter (-
1161 to -615) 
PZEB2Lp1-3 ATCGCGATTAGCAATGCCAACCTCGA 
Amplification of the ZEB2 promoter (-
1161 to -615) 
PZEB2Lp2-5 GGTTCAGTACCCAGTCTCTTGCAT 
Amplification of the ZEB2 promoter (-
735 to -272) 
PZEB2Lp2-3 AAGTGGCATAAGCTACCCTGATAA 
Amplification of the ZEB2 promoter (-
735 to -272) 
PZEB2Lp3-5 TGCGAATGTACCACCCAAGGTTAG Amplification of the ZEB2 promoter (-
 25 
380 to -7) 
PZEB2Lp3-3 TGAATTAAGGTCACGGCCGTT 
Amplification of the ZEB2 promoter (-
380 to -7) 
PZEB2Sp1-5 AACGGCCGTGACCTTAATTCA 
Amplification of the ZEB2S promoter (-
27 to +502) 
PZEB2Sp1-3 TGAGCTATGATCGCCGATAGAAAGGCCT 
Amplification of the ZEB2S promoter (-
27 to +502) 
PZEB2Sp2-5 CCAAACGTCGAATTGGACCAGCCACGCA 
Amplification of the ZEB2S promoter 
(+226 to +625) 
PZEB2Sp2-3 CATTTTCTCCTCGGGCACCATGTCGCGGA 
Amplification of the ZEB2S promoter 
(+226 to +625) 
PPKS4RT-5 TGTGGTATCCTTGTTTTGAAG qRT-PCR of PKS4 transcripts 
PPKS4RT-3 TACCATGAGCCTCCACATACT qRT-PCR of PKS4 transcripts 
PPKS13RT-5 CCAAGACCGTCGAGGATAAGAA qRT-PCR of PKS13 transcripts 
PPKS13RT-3 TCGCTTAGCCAGCTTCTGCATA qRT-PCR of PKS13 transcripts 
PZEB1RT-5 GGACGCACCACCTCAAAAACAT qRT-PCR of ZEB1 transcripts 
PZEB1RT-3 TGGAAAGTGCAGAATGGCCACCT qRT-PCR of ZEB1 transcripts 
PZEB2LRT-5 ATGCAATCTACCGAGTCGTTCCAT qRT-PCR of ZEB2L transcripts 
PZEB2LRT-3 ATTCGACGTTTGGCATTGGTTGTTGAC qRT-PCR of ZEB2L transcripts 
PZEB2RT-5 AGTCGTATTCTCAAGGTTATTCAGGATG qRT-PCR of ZEB2 transcripts 
 26 
PZEB2RT-3 ATATCTCTTGTTGGTAATCATGTGCTTCA qRT-PCR of ZEB2 transcripts 
PCYP1RT-5 TCAAGCTCAAGCACACCAAGAAGG qRT-PCR of CYP1 transcripts 
PCYP1RT-3 GGTCCGCCGCTCCAGTCT qRT-PCR of CYP1 transcripts 
 27 
 For qRT-PCR analyses of ZEA biosynthetic cluster genes, total RNA was 
extracted from 5-day-old cultures of fungal strains constitutively expressing ZEB2 
genes grown in CM. Total RNA (5 μg) was converted into cDNA with the 
SuperScript
TM
 III First-Strand Synthesis System (Invitrogen) using oligo(dT)20 
according to manufacturer’s recommendations, and a 1:100 fraction (corresponding 
to 50 ng of reverse-transcribed RNA) was used for qRT-PCR. All reactions were 
performed in a volume of 20 μl using iQ SYBR Green Master Mix (Bio-Rad, 
Hercules, CA, USA) and a CFX96
TM
 Real-Time System (Bio-Rad) according to the 
manufacturer’s instructions. The thermal profile was 95 °C for 2 min, followed by 
40 cycles of 95 °C for 10 s and 58 °C for 30 s. Three technical replicates were 
performed for all qRT-PCR reactions. The Ct values were normalized to the 
endogenous housekeeping gene cyclophilin (CYP1) for each sample. 
 
IV. Verification of ZEB2 promoter function 
 Fragments corresponding to bp -1166 to -1 (PZEB2L) and bp -27 to +604 
(PZEB2S) of ZEB2 were amplified from wild-type genomic DNA using the primer 
pairs PZLp-5 ApaI/PZLp-3 SpeI and PZSp-5 ApaI/PZSp-3 SpeI, respectively. Full-
length ZEB2 genomic DNA (1.2 kb) was amplified from wild-type genomic DNA 
using PZLO-5 SpeI and PZLO-3 BamHI. The ZEB2S (0.5-kb) ORF was amplified 
from the cDNA library using PZSO-5 SpeI and PZLO-3 BamHI. For the ZEB2L 
construct containing internal start codons that were point-mutated to leucine-
encoding CTG codons (M186L and M192L), two fragments amplified using 
PZEB2Sp1-5/PL2-3 and PL2-5/PZt-3 SacI were fused  and  reamplified  using 
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nested primers (PZLO-5 SpeI and PZLO-3 BamHI). The ZEB2 terminator (227 bp, 
+1207 to +1432 region) was PCR-amplified from Z-3639 genomic DNA using 
PZt-5 HindIII/PZt-3 SacI. These PCR fragments were cloned into pGH-T (Lee et 
al., 2009) to generate pGZT001, which was used to generate plasmids for protein 
expression in F. graminearum. HA and Flag tags were inserted into the BamHI and 
HindIII sites between the ORF and the terminator. After the verification of the 
inserted fragments by sequencing analyses, vectors containing the ZEB2 variants 
were used for fungal transformation (Kim et al., 2005a). To identify ZEB2 proteins 
encoded by alternative promoters, Western blot analysis was performed as 
described below ("Immunoblotting and immunoprecipitation"). The plasmids used 
in this study are listed in Table 3. 
 
V. Yeast two-hybrid (Y2H) assays 
 Y2H assays were conducted using the DUALhunter System (Dualsystems 
Biotech) in accordance with the manufacturer’s instructions. Full-length ZEB2L 
cDNA cloned into the pDHB1 vector was used as the bait vector, which was 
cotransformed with the generated Y2H cDNA library. Saccharomyces cerevisiae 
NMY51 (MAT a his3Δ200 trp1-901 leu2-3, 112 ade2 LYS2::(lexApo)4-HIS3 
ura3::(lexApo)8-lacZ ade2::(lexApo)8-ADE2 GAL4) was used as a host. A total of 
100 positive clones identified by selection on selective medium without Leu, Trp, 
His, or Ade (SD-L-T-H-A) were sequenced. Several truncated ZEB2L constructs 
were cloned into prey vectors, and full-length ZEB2L and ZEB2S inserted into 
pDHB1 were used  as bait vectors. After cotransformation, a colony picked from 
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Table 3. Plasmid constructs used in this study. 
Strain/plasmid Genotype Reference or parents 
pGH-T Binary vector containing a hygromycin resistance gene (Hyg
R
) Lee et al., 2009 
pET28a Cloning vector for constructing N-terminal His6 proteins Novagen 
pDHB1 Cloning vector for a bait in the yeast two-hybrid assay Dualsystems Biotech 
pPR3-N Cloning vector for a prey and a library in the yeast two-hybrid assay Dualsystems Biotech 
pAI-Alg5 Positive control prey vector in the yeast two-hybrid assay Dualsystems Biotech 
pDL2-Alg5 Negative control prey vector in the yeast two-hybrid assay Dualsystems Biotech 
pYB01 pDHB1 derivative expressing ZEB2L (aa 1-363)  This study 
pYB02 pDHB1 derivative expressing ZEB2S (aa 186-363 of ZEB2L)  This study 
pYP03 pPR3-N derivative expressing ZEB2L (aa 1-363)  This study 
pYP04 pPR3-N derivative expressing ZEB2LΔ1-185 (aa 186-363, ZEB2S)  This study 
pYP05 pPR3-N derivative expressing ZEB2LΔ1-128 (aa 129-363)  This study 
pYP06 pPR3-N derivative expressing ZEB2LΔ1-172 (aa 173-363) This study 
pYP07 pPR3-N derivative expressing ZEB2LΔ1-191 (aa 192-363) This study 
pYP08 pPR3-N derivative expressing ZEB2LΔ1-206 (aa 207-363, ZEB2SM)   This study 
pYP09 pPR3-N derivative expressing ZEB2LΔ173-185 (aa 1-172 & 186-363) This study 
pYP10 pPR3-N derivative expressing ZEB2LΔ173-191 (aa 1-172 & 192-363)  This study 
pYP11 pPR3-N derivative expressing ZEB2LΔ186-191 (aa 1-185 & 192-363)  This study 
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pYP12 pPR3-N derivative expressing ZEB2LΔ338-363 (aa 1-337, ZEB2LM)  This study 
pYP13 pPR3-N derivative expressing ZEB2LΔ321-363 (aa 1-320)  This study 
pYP14 pPR3-N derivative expressing ZEB2S Δ1-185 Δ338-363 (aa 186-337)  This study 
pYP15 pPR3-N derivative expressing ZEB2S Δ1-185 Δ321-363 (aa 186-320)  This study 
pBE001 For expression of ZEB2L containing C-terminal His6, cloned into the EcoRI 
and XhoI sites of pET28a  
This study 
pBE002 For expression of ZEB2S containing C-terminal His6, cloned into the EcoRI 
and XhoI sites of pET28a  
This study 
pBE003 For expression of ZEB2Δ1-191 containing C-terminal His6, cloned into the 
EcoRI and XhoI sites of pET28a 
This study 
pGZT001 pGH-T derivatives containing the ZEB2 3’UTR (HindIII-SacI fragment of the 
ZEB2 terminator, TZEB2)  
This study 
pGZ01N pGZT001 derivatives expressing ZEB2-HA. The ZEB2 gene (including the 
ZEB2L promoter, the ZEB2 coding sequence, and a HA linker) was cloned into 
the ApaI and HindIII sites of pGZT001 (PZEB2L-ZEB2-HA-TZEB2-Hyg
R
). 
Ampicillin and hygromycin resistance. 
This study 
pGZ02N pGZT001 derivatives expressing ZEB2L-HA. The ZEB2 gene (including 
ZEB2L promoter, ZEB2L coding sequence containing the mutation of two 
internal start sites [M186L and M192L], and a HA linker) was cloned into the 





Ampicillin and hygromycin resistance. 
pGZ03N pGZT001 derivatives expressing ZEB2S-Flag. The ZEB2S gene (including 
ZEB2S promoter, the ZEB2S coding sequence and a Flag linker) was cloned 
into ApaI and HindIII sites of pGZT001 (PZEB2S-ZEB2S-Flag-TZEB2-Hyg
R
). 
Ampicillin and hygromycin resistance. 
This study 
pGZ003 pGZT001 derivatives overexpressing ZEB2L-HA. The ZEB2 gene (including 
the elongation factor 1α promoter [PEF1α], the ZEB2L coding sequence 
containing the mutation of two internal start sites [M186L and M192L], and a 
HA linker) was cloned into the ApaI and HindIII sites of pGZT001 (PEF1α-
ZEB2L-HA-TZEB2-Hyg
R
). Ampicillin and hygromycin resistance. 
This study 
pGZ004 pGZT001 derivatives overexpressing ZEB2L-Flag. The ZEB2 gene (including 
PEF1α, the ZEB2L coding sequence containing the mutation of two internal start 
sites [M186L and M192L], and a Flag linker) was cloned into the ApaI and 
HindIII sites of pGZT001 (PEF1α-ZEB2L-Flag-TZEB2-Hyg
R
). Ampicillin and 
hygromycin resistance. 
This study 
pGZ005 pGZT001 derivatives overexpressing ZEB2S-Flag. The ZEB2S gene (including 
PEF1α, the ZEB2S coding sequence, and a Flag linker) was cloned into the ApaI 
and HindIII sites of pGZT001 (PEF1α-ZEB2S-Flag-TZEB2-Hyg
R
). Ampicillin and 
hygromycin resistance. 
This study 
pGZ006 pGZT001 derivatives overexpressing ZEB2S-Myc. The ZEB2S gene This study 
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(including PEF1α, the ZEB2S coding sequence, and a Myc linker) was cloned 
into the ApaI and HindIII sites of pGZT001 (PEF1α-ZEB2S-Myc-TZEB2-Hyg
R
). 
Ampicillin and hygromycin resistance. 
pGZ007 pGZT001 derivatives overexpressing ZEB2LM-Flag. The ZEB2LM gene 
(including PEF1α, the ZEB2LM coding sequence [ZEB2LΔ338-363], and a Flag 
linker) was cloned into the ApaI and HindIII sites of pGZT001 (PEF1α-
ZEB2LM-Flag-TZEB2-Hyg
R
). Ampicillin and hygromycin resistance. 
This study 
pGZ012 pGZT001 derivatives overexpressing ZEB2LM-HA. The ZEB2LM gene 
(including PEF1α, the ZEB2LM coding sequence [ZEB2LΔ338-363], and a HA 
linker) was cloned into the ApaI and HindIII sites of pGZT001 (PEF1α-
ZEB2LM-HA-TZEB2-Hyg
R
). Ampicillin and hygromycin resistance. 
This study 
pGZ013 pGZT001 derivatives overexpressing ZEB2SM-Flag. The ZEB2SM gene 
(including PEF1α, the ZEB2SM coding sequence [ZEB2LΔ1-206], and a Flag 
linker) was cloned into the ApaI and HindIII sites of pGZT001 (PEF1α-
ZEB2SM-Flag-TZEB2-Hyg
R
). Ampicillin and hygromycin resistance. 
This study 
pGZ014 pGZT003 derivatives overexpressing ZEB2L-GFP. The GFP gene (including a 
glycine linker and the GFP reporter gene) was cloned into the BamHI and 
HindIII sites of pGZT003 (PEF1α-ZEB2L-GFP-TZEB2-Hyg
R
). Ampicillin and 
hygromycin resistance. 
This study 
pGZ015 pGZT005 derivatives overexpressing ZEB2S-RFP. The RFP gene (including a This study 
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glycine linker and the RFP reporter gene) was cloned into the BamHI and 
HindIII sites of pGZT005 (PEF1α-ZEB2S-RFP-TZEB2-Hyg
R
). Ampicillin and 
hygromycin resistance. 
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the SD-Leu-Trp plates was grown in liquid SD-Leu-Trp, subjected to four-fold 
serial dilutions, and spotted on selective plates. Empty vector and pDL20-Alg5 (-) 
were included as negative controls, and pAl-Alg5 (+) was included as a positive 
control. 
 
VI. Immunoblotting and immunoprecipitation 
ZEB2 variants fused to HA, Flag, or Myc were cloned into the SpeI-
HindIII site in pGZT001. For the constitutive expression of the ZEB2 gene in CM, 
the elongation factor 1α promoter (PEF1α) was amplified from pSKGEN (Lee et al., 
2011b) using the primers PEFp-5 ApaI and PEFp-3 SpeI; then, PEF1α was inserted 
into each vector.  
 For the coimmunoprecipitation assay, fungal strains coexpressing different 
tagged ZEB2 variants were generated by outcrossing (Table 1). Filtered fungal 
mycelia cultures were homogenized to a fine powder under liquid nitrogen using a 
mortar and pestle. Powdered fungal cultures (50 mg) were sonicated in 250 μl of 
lysis buffer (25 mM Tris-HCl, pH 7.4; 150 mM NaCl; 5% glycerol; 1% NP-40; 1 
mM EDTA; and protease inhibitors), boiled for 5 min in loading buffer, and 
subjected to SDS-PAGE analysis. After membrane transfer, the nitrocellulose 
membranes were immunoblotted with rabbit anti-HA (Abcam, Cambridge, UK, 
1:4,000), mouse anti-Flag (Sigma-Aldrich, 1:4,000), and rabbit anti-β-tubulin 
(Abcam, 1:2,000) primary antibodies followed by horseradish peroxidase-linked 
secondary antibodies (GE Healthcare, Buckinghamshire, UK, 1:4,000). The target 
proteins were visualized using ECL Select
TM
 Western Blotting Detection Reagent 
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(GE Healthcare) according to the manufacturer’s protocol.  
 For immunoprecipitation, the lysates were incubated in magnetic beads 
conjugated to a mouse anti-Flag antibody (Sigma-Aldrich) at 4 °C overnight and 
were washed five times with lysis buffer prior to resolution via SDS-PAGE 
analysis (12.5%). Western blot analysis was performed according to the techniques 
described above. 
 
VII. Mycotoxin analyses 
 The ZEA extraction and quantification procedures were performed as 
previously documented (Kim et al., 2005b). Briefly, a filtrate extracted with ethyl 
acetate was concentrated to dryness and dissolved in methanol-water (65:35, v/v) 
for HPLC analysis or in methanol for TLC analysis. A Shimadzu LC-10 AD HPLC 
equipped with an RF-10A fluorescence detector (Shimadzu, Kyoto, Japan) was 
used for the analysis. A Symmetry C18 column (15 mm × 4.6 mm; particle size, 5 
μm; Waters Corp., Milford, MA, USA) was used at a detection wavelength of 274-
466 nm. The mobile phase was 65% aqueous methanol, and the flow rate was 1.3 
ml min
-1
. The methanol aliquot of each sample was separated in the developing 
solvent, chloroform-methanol (9:1, v/v), on silica gel-coated TLC plates (Kiesel 
Gel 60, Merck, Darmstadt, Germany). Photographs were obtained after exposure to 
UV radiation (254-364 nm). 
 
VIII. ZEB2 isoform subcellular localization 
 GFP and RFP were amplified from pIGPAPA and pLC25 using the primer 
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pairs PGFP-5 BamHI/PGFP-3 HindIII and PRFP-5 BamHI/PRFP-3 HindIII, 
respectively. The resulting PCR products and 6× glycine linkers were cloned into 
the corresponding enzyme sites of the pGZ003 and pGZ005 plasmids to generate 
pGZ014 and pGZ015, respectively. These plasmids were transformed into the 
ZEB2 truncation mutants. The resulting transformants (FAZ017 and FAZ018) were 
outcrossed with mat1g or mat1r to generate FAZ22 and FAZ23, respectively, for 
the visualization of the nuclei using GFP or RFP (Son et al., 2011a; Hong et al., 
2010). To assess the colocalization of ZEB2L-GFP and ZEB2S-RFP, the Δmat1 
strain (Lee et al., 2003) was fertilized with FAZ018 to generate FAZ018C. Next, 
the FAZ017 strain was outcrossed with FAZ018C to generate FAZ021. The 
heterothallic Δmat1 strain carrying a MAT1-1-1 deletion was used as a tester strain 
for the outcross. Microscopic examinations were performed using a DE/Axio 
Imager A1 microscope (Carl Zeiss, Jena, Germany) equipped with a 38HE filter set 
(excitation 470/40; emission 525/50) for GFP and a 15 filter set (excitation 546/12; 
emission 590) for RFP. 
 





 were amplified from pUC-SPYNE and pUC-SPYCE 
(Walter et al., 2004) using the primer pairs PYFPNE-5 BamHI/PYFPNE-3 HindIII 
and PYFPCE-5 BamHI/PYFPCE-3 HindIII, respectively. The resulting PCR 
products and 6× glycine linkers were cloned into the BamHI-HindIII sites of 
pGZ003, pGZ005, and pGZ007. The resulting plasmids were transformed into the 
ZEB2 truncation mutants. The normal expression of the ZEB2 fusion variants by 
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each transformant was confirmed by Western blot analysis. Various outcrosses 
were applied to generate strains coexpressing both ZEB2 fusion variants (Table S1). 
Microscopic examinations were performed using a DE/Axio Imager A1 
microscope (Carl Zeiss) equipped with the 46 filter set (excitation 500/20; emission 
535/30) for YFP. 
 
X. Electrophoretic mobility shift assay (EMSA) 
 ZEB2L, ZEB2S, or ZEB2 Δ1-191 cDNA was cloned into the pET28a vector 
(Novagen, Madison, WI, USA) and expressed as a His6-fusion protein in the E. coli 
BL21-CodonPlus (DE3)-RIL strain (Stratagene, La Jolla, CA, USA) by adding 
isopropyl--D-thiogalactopyranoside at a final concentration of 0.5 mM. 
Recombinant proteins were purified using a Ni Sepharose
TM
 6 Fast Flow column 
(GE Healthcare). PKS4, PKS13, ZEB1, and ZEB2 double-stranded DNA probes (2 
pmol) were labeled using T4 polynucleotide kinase (Takara Korea Biomedical Inc., 
Seoul, Korea) and 20 µCi [γ-
32
P]ATP (6,000 Ci mmol
-1
, Perkin Elmer, Boston, MA, 
USA). EMSA binding reactions were performed in 15-µl volumes. In total, 15–120 
nM of purified recombinant protein and labeled probes (0.04 pmol) were incubated 
for 20 min at room temperature in a buffer containing 10 mM Tris-HCl (pH 7.5), 4 
mM HEPES (pH 7.9), 50 mM NaCl, 1 mM MgCl2, 0.54 mM EDTA, 8% (v/v) 
glycerol, 0.1 mM DTT, 40 µg of BSA, and 2 µg of poly(dI-dC). The reactions were 
electrophoresed on 4% polyacrylamide gels (acrylamide:Bis ratio of 29:1 w/w; 
Bio-Rad). The DNA complex bands were visualized with a BAS-2500 Bio-image 
Analyzer (Fujifilm, Tokyo, Japan).  
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 For competitive binding experiments, 50-fold molar excess of nonlabeled 
DNA elements were included in the reaction solution prior to incubation in the 
purified proteins. The β-tubulin promoter region was used as a nonspecific 
competitor. DNA fragments containing identical nucleotide sequences to the probes 
were used as specific competitors. The PKS4, PKS13, and ZEB1 promoters were 
incubated in 15 nM ZEB2 protein. The ZEB2 promoters were incubated in 30 nM 
ZEB2 protein.  
 For competitive EMSA assays, the ZEB2L promoter-derived probe was 
incubated in 40 nM ZEB2L for 20 min, followed by the application of increasing 
concentrations of ZEB2S for an additional 20 min at room temperature. ZEB2Δ1-
191 was used as a negative control for competitive EMSA. The complexes were 
visualized as described above. 
 
XI. 2-D native/SDS-PAGE 
 Native separating gels were prepared using 5–15% acrylamide 
(acrylamide:Bis ratio of 37.5:1 w/w; Bio-Rad) in 0.375 M Tris-HCl (pH 8.8). The 
samples were electrophoresed at 25 mA at 4 °C in 1× gel buffer (10 mM Tris-
glycine, pH 8.7). The channels to be used for SDS-PAGE were carefully sliced 
from the native gel; equilibrated for 15 min in 5 ml of a buffer containing 0.05 M 
Tris-HCl (pH 6.8), 2.3% SDS, 10% glycerol, and 5% β-mercaptoethanol; and 
heated in a microwave for 20 s. Electrophoresis was performed at 20 mA for 
approximately 2.5 h. The NativeMARK Unstained Protein Standard (Invitrogen) 
was used to determine the molecular weights of the proteins on native PAGE. 
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ZEB2 expression was detected by Western blot analysis with an anti-HA antibody. 
 
XII. Size-exclusion chromatography 
 Fungal lysates were extracted from the FAZ012 (ZEB2L-HA/ZEB2L-
Flag), FAZ006 (ZEB2L-HA/ZEB2S-Flag), and FAZ013 (ZEB2S-Myc/ZEB2S-
Flag) strain CM cultures with lysis buffer; purified using an anti-Flag column; and 
dialyzed with FPLC running solution (0.1 M glycine, pH 3.5; 0.01% NP-40; 1 mM 
EDTA; and 5% glycerol). The oligomeric states of the purified fungal ZEB2 
proteins were analyzed via AKTA FPLC using a Superdex
TM
 200 10/300 GL 
column (GE Healthcare). The results were confirmed by Western blot analyses. 
 
XIII. Induction of ZEB2 transcription by exogenous ZEA 
treatment 
 The wild-type strain Z-3639 and the ZEA-deficient mutants Δpks4 and 
Δpks13 were grown in 25 ml of SG medium supplemented with 0, 0.1, or 1 ppm 
ZEA. The mycelia of each strain after 0, 2, 4, 6, 8, 10, and 12 days of incubation 
were harvested by filtration through Whatman No. 2 filter paper. Northern blot and 
TLC analyses of each culture were performed as described above. DNA probes 
specific to the C-terminus of ZEB2 (PZ577-5/PZ790-3 for probe 3) were used for 
Northern blot analyses. 
 
XIV. Nucleotide sequence accession numbers 
 The ZEB2L and ZEB2S exon sequences were deposited in the GenBank 
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I. Characterization of two transcripts of the ZEB2 gene 
 Our previous study suggested that two distinct ZEB2 transcripts are formed 
during ZEA production (Kim et al., 2005b). I performed cDNA sequencing 
analyses of ZEB2 using the F. graminearum cDNA library to confirm these results 
and found that ZEB2 contains two introns and multiple alternative transcription 
start sites. The proteins translated from the longer 1.2-kb and shorter 0.7-kb ZEB2 
transcripts were designated ZEB2L and ZEB2S, respectively (Fig. 1 and Fig. 2A). 
ZEB2L contains a bZIP DNA-binding domain at the N-terminus, whereas ZEB2S 
is an N-terminally truncated form of ZEB2L that lacks the bZIP domain. 
 Next, I performed Northern blot analyses with various probes derived from 
the upstream (probes 1 and 2) and downstream (probes 3 and 4) regions of the 
translation start site (+605) of the ZEB2S gene. The results verified the presence of 
the two ZEB2 transcripts (Fig. 2B). The exogenous supplementation of ZEA with 
starch-glutamate (SG) liquid medium enhanced the transcription of the ZEB2 gene, 
as previously reported (Lee et al., 2011a). During ZEA biosynthesis, the expression 
of ZEB2L transcripts was detected at 3 days of incubation, increased up to 6 days, 
and disappeared by 10 days. In contrast, ZEB2S transcripts were detected after 5 
days of incubation and remained until 10 days (Fig. 3). 
 I hypothesized that ZEB2 gene expression is regulated by alternative 
promoters based on the presence of multiple transcription start sites and an N-
terminally truncated isoform. Therefore, I examined whether the putative promoter 






Fig. 1. ZEB2 nucleotide and deduced amino acid sequences. The nucleotide positions are provided relative to the first 
translational start site of ZEB2L. The blue letters with asterisks indicate two different translation start sites. The red letters with 
bent arrows indicate the transcription start sites. The capital letters below the nucleotide sequences represent the amino acid 
sequences. The two "M"s in circles indicate the start codon sites that were point-mutated to leucine in the ZEB2L constructs 
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Fig. 2. ZEB2 gene expression is mediated by alternative promoter usage. 
A. Schematic representation of the ZEB2 gene and protein structures. ZEB2 comprises two introns (dashed lines) and multiple 
transcription initiation sites (bent arrows). The resulting transcripts encode two proteins: ZEB2L and ZEB2S. Only ZEB2L 
contains a bZIP DNA-binding domain. Each Northern blot analysis probe used in B is illustrated as a black bar corresponding to 
the cDNA region. 
B. Verification of the two ZEB2 transcripts by Northern blot analysis. Total RNA was extracted from 6-day-old wild-type 
cultures in SG medium lacking (lane 1 for each blot) or containing 1 ppm ZEA (lane 2 for each blot). The utilized probe is 
indicated above each blot. 
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Fig. 3. ZEB2 transcript profile throughout ZEA biosynthesis. Total RNA was 
extracted from cultures grown in SG medium for 3-10 days. Ethidium bromide-
stained rRNA was included as a loading control. 
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carrying intact ZEB2 open reading frame (ORF) genomic fragments under the 
control of the putative ZEB2L promoter region (PZEB2L) expressed both ZEB2L 
(~45 kDa) and ZEB2S (~23 kDa) (Fig. 4A). When the two internal start codons 
were substituted with leucine, the resulting strain (FAZ003) only produced the 
ZEB2L isoform (Fig. 4B). The region between positions –27 and +604 (designated 
the ZEB2S promoter [PZEB2S]) served as a regulatory element that enabled the 
expression of ZEB2S, suggesting that PZEB2S is a functional alternative promoter 
(Fig. 4C). 
 
II. Identification of ZEB2 interaction partners in vitro and in vivo 
I used a yeast two-hybrid (Y2H) system to screen for proteins associated 
with ZEB2L because bZIP TFs typically function as dimers. In a screen of 1 × 10
7
 
yeast cells cotransformed with a bait vector expressing ZEB2L and a F. 
graminearum cDNA library, the only positive clone possessed the ZEB2S-
encoding sequence. Additional Y2H analyses revealed that both ZEB2 isoforms 
strongly interact with each other (Fig. 5). I mapped the ZEB2L- and ZEB2S-
interaction domains by generating several deletion mutants (Fig. 5 and Fig. 6). Two 
interaction domains, ID1 (173-206) and ID2 (338-363), were found to be required 
for ZEB2L-ZEB2L, ZEB2L-ZEB2S, and ZEB2S-ZEB2S dimerization. In ZEB2L, 
the N-terminal region (173-191) of ID1 was important for these interactions; 
however, its C-terminal region (186-206) in ZEB2S was necessary for these 
interactions (see data concerning the ZEB2L-truncated forms Δ173-185 and Δ173-
191 in Fig. 6). ID2 in both ZEB2 isoforms was important for their dimerization.
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Fig. 4. ZEB2 isoform expression driven by the native promoters. Western blot analyses with anti-HA and anti-Flag antibodies 
were performed to verify the production of the corresponding proteins. An illustration of the transformed fungal construct used 
is included above each blot. In the PZEB2L-ZEB2L-HA construct, the internal start codons were mutated to leucine-encoding CTG 
codons (M186L and M192L). PZEB2L (-1166 to -1) and PZEB2S (-27 to +604) were the functional promoters for ZEB2L and ZEB2S, 





Fig. 5. Yeast coexpression assays. A series of ZEB2L-deleted derivatives was used 
for the Y2H assays. Cell growth on selective medium without Leu, Trp, His, or Ade 
(SD-L-T-H-A) indicates positive interactions. Each strain was spotted in four-fold 
serial dilutions. pDHB1 was used as the bait vector (pBD), and pPR3-N was used 
as the prey vector (pAD). Empty vector and pDL20-Alg5 (-) were included as 




Fig. 6. Map of ZEB2-interacting domains. A series of ZEB2L truncation constructs was used in Y2H assays. ID1 and ID2 
indicate the locations of the protein-protein interaction domains. Interactions were scored according to the number of positive 
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To confirm that the ID1 and ID2 regions are critical for protein-protein 
interactions among ZEB2 isoforms in vivo, I generated F. graminearum strains 
coexpressing different ZEB2 variants tagged with HA, Flag, or Myc via fungal 
transformation and outcrossing (Table 1 and Fig. 7A). Using protein extracts from 
those strains, I found that ZEB2L and ZEB2S coimmunoprecipitated, supporting 
the findings from the Y2H analyses (Fig. 7B). As predicted, no interactions were 
detected between the ZEB2 isoforms and the ZEB2-truncated derivatives that 
lacked an interaction domain (LM and SM, shown in Fig. 7A). 
 To investigate the subcellular localization of the ZEB2 isoforms, I 
generated F. graminearum strains overexpressing the ZEB2 isoforms fused to green 
or red fluorescent protein (GFP or RFP, respectively). The ZEB2L-GFP fusion 
proteins localized exclusively to the nucleus, whereas the ZEB2S-RFP fusion 
proteins localized to both the cytosol and the nucleus (Fig. 8). To analyze the 
interactions between these proteins in vivo, bimolecular fluorescence 
complementation (BiFC) analysis was employed. Multiple outcrosses were utilized 
to generate F. graminearum strains possessing ZEB2 fusion proteins containing 
both halves of YFP (Table 1). Each transformant expressed ZEB2 proteins fused to 




, respectively), as determined by 
Western blot analyses (Fig. 9). The BiFC analyses revealed interactions between 
ZEB2L and ZEB2L, as well as between ZEB2L and ZEB2S, in the nucleus (Fig. 
10). In accordance with the subcellular localization of ZEB2S, the ZEB2S-ZEB2S 
interaction was detected in both the cytosol and the nucleus. Strains expressing 
ZEB2-truncated derivatives lacking an interaction domain did not show any 








Fig. 7. Identification of ZEB2-interacting proteins. 
A. Schematic representation of the ZEB2 proteins used in the immunoprecipitation 
assays. The two internal start codons of the "L" and "LM" constructs were mutated 
to leucine-encoding CTG codons (M186L and M192L). Each ZEB2 recombinant 
was tagged with HA, Flag, or Myc. The interacting domains (ID1 and ID2) are 
indicated. 
B. ZEB2 immunoprecipitation assay. Each transformed strain lysate carrying the 
corresponding ZEB2 protein was analyzed by immunoprecipitation using the anti-
Flag antibody, followed by immunoblotting with the anti-HA or anti-Myc antibody. 











Fig. 9. Verification of ZEB2 fusion protein expression in the transformants used for 





immunoblotted using anti-Myc and anti-HA antibodies, respectively. The protein 







Fig. 10. BiFC visualization of ZEB2 dimerization in F. graminearum. YFP fluorescence, DIC, and merged images are shown 
for each transformation. Scale bars: 10 μm. 
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ZEB2L-ZEB2L, ZEB2L-ZEB2S, and ZEB2S-ZEB2S complexes. 
 
III. ZEB2 isoforms bind to ZEA biosynthetic cluster gene 
promoters, and ZEB2L expression promotes ZEA biosynthesis 
Using an electrophoretic mobility shift assay (EMSA) approach, I assessed whether 
ZEB2L directly binds to the promoter regions of PKS4, PKS13, ZEB1, and ZEB2. 
The putative promoter regions of these biosynthetic cluster genes were subdivided 
into several DNA fragments and were tested (Fig. 11). Purified recombinant 
ZEB2L, ZEB2S, and ZEB2Δ1-191 proteins were used for this assay (Fig. 12). 
ZEB2L formed shifted complexes with the PKS4, PKS13, ZEB1, and ZEB2L 
promoters, but it did not interact with the ZEB2S promoter (PZEB2S) under these 
conditions. ZEB2S did not bind to any of the tested promoter regions (Fig. 13). 
These results confirmed that ZEB2L directly binds to the putative promoters of 
ZEA biosynthetic cluster genes. Moreover, the results suggested that ZEB2L forms 
more stable complexes with the PKS4, PKS13, and ZEB1 promoters than with the 
ZEB2L promoter in vitro, as smeared signals often appear when protein-DNA 
complexes are unstable. Next, I used competitive EMSA to examine the effect of 
the ZEB2L-ZEB2S interaction on ZEB2L DNA-binding activity (Fig. 14). The 
mobility shift caused by incubating ZEB2L in the presence of the ZEB2L promoter 
markedly decreased as the ZEB2S concentration increased, suggesting that ZEB2S 
inhibits the DNA-binding activity of ZEB2L on the ZEB2L promoter. When 
ZEB2Δ1-191, the truncated form of ZEB2S, was used as a nonspecific negative 




Fig. 11. EMSA analyses to identify ZEB2L DNA-binding regions. EMSA analyses of 
32
P-labelled PKS4, PKS13, ZEB1, and 
ZEB2 putative promoter fragments were conducted using increasing concentrations of purified ZEB2L. The gene name and the 
promoter region are indicated above each blot. β-tubulin gene promoter fragments were used as negative controls.
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Fig. 12. Purified recombinant ZEB2 proteins. Purified proteins were analyzed via 12.5% SDS-PAGE. ZEB2Δ1-191 represents 






Fig. 13. EMSA analyses of ZEB2 isoforms and ZEA biosynthetic cluster gene promoters. Where indicated, a 50-fold excess of 







Fig. 14. Effect of ZEB2S on the DNA-binding activity of ZEB2L. ZEB2 isoform 
mixtures at specific concentrations were used for competitive EMSA analyses with 
the ZEB2L promoter fragments. ZEB2Δ1-191 protein was added to the competitive 




 To determine the roles of each ZEB2 isoform in ZEA biosynthesis, I 
produced strains overexpressing ZEB2L (FAZ001), ZEB2S (FAZ002), or both 
isoforms (FAZ006). The expression of the ZEB2 isoform in each strain was 
verified by Western blot analysis and quantitative real-time PCR (qRT-PCR). ZEA 
production was tested using thin-layer chromatography (TLC). The FAZ001 strain 
produced ZEA (L in Fig. 15), whereas the FAZ002 strain did not produce ZEA (S 
in Fig. 15). No ZEA production was detected in the strain (FAZ006) that 
coexpressed ZEB2L and ZEB2S (L+S in Fig. 15). These results are representative 
of three independent transformants for each construct (Fig. 16). 
 Transcripts of ZEA biosynthetic cluster genes (PKS4, PKS13, and ZEB1) 
were detectable by qRT-PCR only in the strains expressing ZEB2L alone (Fig. 17). 
Taken together, these results suggested that ZEB2L is an activator and that ZEB2S 
is an inhibitor of ZEA biosynthesis.  
 
IV. ZEB2 isoform profiles during ZEA production 
 To analyze the correlation between ZEB2 isoform accumulation and ZEA 
production, I examined the levels of ZEA produced by a fungal strain (FAZ03N) 
carrying HA-tagged intact ZEB2 proteins under the control of the native ZEB2 
promoter in SG liquid medium (Fig. 18). ZEA was initially detected at 2 days of 
incubation (21 ng ml
-1
). The ZEA level increased until day 10 (598 ng ml
-1
), and 
the graph of ZEA production over time exhibited a sigmoidal shape. The same 









Fig. 15. ZEB2 isoform coexpression inhibits ZEA production. 
A. Expression of ZEB2 isoforms. Western blot analyses with anti-HA and anti-
Flag antibodies were performed to verify the production of the corresponding 
proteins. An illustration of the construct used for fungal transformation is located 
above the blots. In the PEF1α-ZEB2L-HA construct, the internal start codons were 
mutated to leucine-encoding CTG codons (M186L and M192L). 
B. ZEA production. Each construct expressed by the corresponding fungal strain is 
indicated above each blot. ZEA production was detected by TLC analysis. The 





Fig. 16. Expression of ZEB2 isoforms and ZEA production. L, S, and L+S indicate 
F. graminearum strains overexpressing ZEB2L (FAZ001), ZEB2S (FAZ002), or 
both ZEB2 isoforms (FAZ006), respectively. Western blot analyses using anti-HA 
and anti-Flag antibodies were performed to verify the production of the 
corresponding proteins. ZEA production was detected by TLC analysis. Three 








Fig. 17. Expression of ZEA biosynthetic cluster genes in F. graminearum strains 
overexpressing ZEB2L, ZEB2S, or both ZEB2 isoforms. The transcript levels of 
ZEB2L, ZEB2 (L+S), PKS4, PKS13, and ZEB1 were analyzed by qRT-PCR in the 
FAZ001 (L), FAZ006 (L+S), and FAZ002 (S) strains. The expression of the 
transcripts was normalized to that of the housekeeping gene CYP1. The transcript 
levels in the fungal strain overexpressing only ZEB2L were arbitrarily normalized 






Fig. 18. ZEA production by the fungal strain (FAZ03N). The time course of ZEA 
production was monitored by HPLC analysis.
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type strain (Z-3639) (Fig. 19). Next, I performed Western blot analyses to profile 
the ZEB2 isoforms present during ZEA production (Fig. 20). The ZEB2L levels 
decreased as ZEB2S appeared at 6 and 8 days of incubation, and ZEB2L was 
barely detectable by day 10. In contrast, ZEB2S was not detected until 5 days of 
incubation, when its levels were low. Then, the ZEB2S levels were increased at 6, 
8, and 10 days. These results suggested that ZEA production is initiated by ZEB2L 
but is terminated by high levels of ZEB2S, which exerts a negative effect on ZEA 
biosynthesis by reducing the ZEB2L protein levels. 
 
V. Oligomeric states of ZEB2 isoforms 
 To investigate the exact oligomeric states of ZEB2 isoforms during ZEA 
production, I utilized a two-dimensional (2-D) electrophoresis system involving 
native PAGE followed by SDS-PAGE. When ZEB2L alone accumulated in the 
early stage (3 days of incubation) of ZEA production (Fig. 20), ZEB2L existed 
either as oligomers (possibly homotetramers [~180 kDa]) or monomers (~45 kDa) 
(Fig. 21). During the middle stage of ZEA production (from days 6 to 8), ZEB2L 
formed heterodimers with ZEB2S (~70 kDa). ZEB2S homodimers (~45 kDa) were 
detected after day 8. During the late stage of ZEA production, only ZEB2S 
homodimers (~45 kDa) accumulated to detectable levels. 
 I also performed size-exclusion chromatography analyses using strains that 
expressed both ZEB2 isoforms (L+S, FAZ006) or ZEB2S alone (S, FAZ013). The 
elution peaks of the lysates from these two strains were slightly shifted to 






Fig. 19. ZEA production in wild-type strains. The time course of ZEA production 






Fig. 20. Profile of ZEB2 isoform expression during ZEA biosynthesis. Western 
blot analyses using the anti-HA antibody were performed to profile ZEB2 isoform 
production during ZEA biosynthesis. β-tubulin was used as a loading control for 
the extracts. The incubation times are indicated above the blot. The protein 






Fig. 21. Western blot analyses of native ZEB2 multi-oligomeric complexes by 2-D 
electrophoresis. A fungal strain (FAZ03N) producing both ZEB2 isoforms was 
used for the analysis. Total lysates were separated by native PAGE (5–15% 
acrylamide gradient). Next, 1-D gel products were subjected to denatured SDS-
PAGE, followed by Western blot analysis with the anti-HA antibody. The protein 









Fig. 22. Multi-oligomeric states of the ZEB2 complexes. 
A. Size-exclusion chromatography profiles of ZEB2 multi-oligomeric complexes. 
Fungal strains expressing both ZEB2 isoforms (L+S, FAZ006) or ZEB2S alone (S, 
FAZ013) were used. Size-exclusion chromatography elution profiles are shown for 
the homo-oligomeric ZEB2S complex (orange line) and the mixed oligomeric 
ZEB2L-ZEB2S or ZEB2S-ZEB2S complexes (blue line). Arrows and dashed lines 
indicate molecular markers. 
B. Western blot analyses of the fractions collected via size-exclusion 
chromatography. F1–5 represent the fractions used for Western blot analyses in A. 
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primarily detected in the F2 fraction  of the  FAZ006 strain.  ZEB2S homodimers 
were detected in the F3 and F4 fractions of both strains (Fig. 22B). These data support 
the findings regarding the native oligomeric states of these ZEB2 isoforms. ZEB2L 
homo-oligomers could not be purified due to poor solubility. 
 
VI. Induction of ZEB2 transcription by exogenous addition of ZEA 
 To investigate effects of ZEA on ZEB2 expression, I added ZEA to the wild-type 
cultures. Exogenous treatment of ZEA (0.1 ppm) induced the expression of both the 
ZEB2L and ZEB2S transcripts at the early stage of ZEA production compared to the 
untreated control (Fig. 23). The transcript levels of ZEB2S tended to be more markedly 
increased than those of ZEB2L under the conditions of ZEA supplementation. At 8 days 
of incubation, the transcript levels of ZEB2S were higher in the presence of ZEA 
treatment than in the absence of ZEA treatment; alternatively, the transcript levels of 
ZEB2L were nearly undetectable in the presence of ZEA, in contrast to the untreated 
control. Similar to the ZEB2L transcript levels, ZEA accumulated more rapidly upon 
ZEA supplementation compared to the untreated control. 
 I also used the ZEA-deficient strains to verify the effect of ZEA on ZEB2 
expression. In accordance with a previous report (Kim et al., 2005b), ZEB2 transcripts 
were rarely detected in Δpks4 and Δpks13 in the absence of ZEA supplementation (Fig. 
24). However, both mutant strains produced similar transcript levels of these two ZEB2 
isoforms to the wild-type strain upon ZEA supplementation until 4 days of incubation 
(Fig. 24). Similar to those in the wild-type strain, the transcript levels of ZEB2L were 
dramatically decreased at 4 days, when the ZEB2S  transcript  levels were high. Taken 
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together, these results suggested that ZEA itself plays a role in an autoregulatory 






Fig. 23. Effect of ZEA treatment on the ZEB2 transcription and ZEA production profiles. The concentration of supplemented 






Fig. 24. ZEA triggers the induction of ZEB2 transcription. Induction of ZEB2 transcription by ZEA treatment in the transformed 
ZEA-deficient strains. ZEA and total RNA were extracted from F. graminearum cultures with or without ZEA supplementation 
for 0-12 days. ZEA production was detected by TLC analysis. The incubation times are indicated above each blot. Ethidium 
bromide-stained rRNA was included as a loading control. 
 83 
DISCUSSION 
 Alternative promoter usage and alternative splicing mechanisms contribute 
to protein diversity in the eukaryotic genome (Keren et al., 2010). Alternative 
promoters have different tissue specificities and developmental activities, and 
several alternative promoters enable the formation of various feedback loops 
(Pozniak et al., 2000; Molina et al., 1993). For example, inducible cAMP early 
repressor (ICER, a cAMP-responsive element modulator isoform) is expressed via 
an alternative promoter and represses the activity of its own promoter through a 
negative autoregulatory mechanism in human cells (Molina et al., 1993). Although 
up to 58% of human genes are regulated by alternative promoters, the functional 
significance and biological roles of alternative promoters remain largely 
unexplored (Kimura et al., 2006). Lower levels of alternative transcripts are 
predicted to be present in fungi than in animals (Loftus et al., 2005), but few 
studies have examined fungal alternative promoters and their biological functions. 
 In this study, I demonstrated that the ZEB2S isoform plays a functional 
role in the inhibition of ZEA biosynthesis. I propose a novel regulatory mechanism 
for ZEA biosynthesis that involves the dimerization of the ZEB2L and ZEB2S 
isoforms under conditions favoring ZEA production (Fig. 25). In the early stage of 
the ZEA biosynthetic pathway, ZEB2L oligomers activate the ZEA biosynthetic 
cluster genes and ZEB2 itself, resulting in the initiation of ZEA biosynthesis. 
ZEB2L is induced by environmental stimuli such as temperature, humidity, and 
nutrition (Naik et al., 1978; Hesseltine, 1976). As ZEA biosynthesis progresses, 






Fig. 25. Proposed model of ZEB2 autoregulation. After the initial induction of 
ZEB2, ZEB2L (L in green circle) is produced. The resulting homo-oligomers of 
ZEB2L (L in the green oval) directly activate ZEA biosynthetic cluster genes and 
ZEB2L during the early stage of ZEA production (Initiation). ZEA (red circle) 
affects the expression of ZEB2 directly or indirectly, and ZEB2S transcripts are 
expressed by an alternative promoter. More ZEB2S transcripts are induced than 
ZEB2L transcripts as the ZEA level increases. During the processing step, ZEB2S 
(S in the orange circle) begins to accumulate, and the DNA-binding activities of the 
ZEB2L homo-oligomers are gradually eliminated by the production of ZEB2 
heterodimers (ZEB2L-ZEB2S). Finally, ZEB2L transcription is completely 
terminated; only ZEB2S dimers remain. The green oval with a dotted line 
represents gradually reduced ZEB2L homo-oligomer levels. The grey ovals 




transcripts are expressed by an active alternative promoter. ZEA enhances both 
ZEB2 transcripts, but more ZEB2S transcripts are formed than ZEB2L transcripts as 
the concentration of ZEA increases. ZEB2S inhibits ZEB2L transcription by 
forming ZEB2L-ZEB2S heterodimers, which reduce the DNA-binding activity of 
the ZEB2L oligomers. Because only a small portion of total ZEB2S is localized to 
nuclei (Fig. 2D), ZEB2L expression and ZEA production are not shut down as soon 
as ZEB2S transcription is induced. ZEA continues to be produced at this stage; 
however, the rate of ZEA production gradually decreases due to reduced ZEB2L 
levels. Finally, ZEB2L transcription is terminated due to the ZEA-induced increase 
in the ZEB2S levels, which ceases ZEA production. 
 The ZEA biosynthesis pathway is an archetypal example of autoregulation 
via the TF protein diversity caused by alternative promoter usage and feedback 
loop mechanisms, in which ZEA upregulates ZEB2S expression to maintain the 
appropriate levels of ZEA in the fungal cell. However, in contrast to previously 
characterized cases, such as human ICER, ZEB2S does not possess DNA-binding 
activity. Rather, ZEB2S interacts with ZEB2L to form a ZEB2L-ZEB2S 
heterodimer that inhibits ZEB2L from binding to the promoter of the ZEB2L gene. 
 In filamentous fungi, the CPCA of Aspergillus nidulans is an example of a 
homologous transcriptional regulator. CPCA directly binds to the CPCA 
recognition element in the CpcA promoter and activates its transcription under 
amino acid starvation conditions (Hoffmann et al., 2001). Frequency (frq), a 
component of the circadian clock in Neurospora crassa, is negatively autoregulated 
by its own gene product, thus creating a feedback loop (Aronson et al., 1994). 
However, both the ZEB2L and ZEB2S isoforms participate in the autoregulation of 
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ZEB2 as an activator and an inhibitor, respectively. To my knowledge, no 
autoregulatory mechanism for ZEB2 expression has been reported in filamentous 
fungi. 
 In general, bZIP TFs form hetero- and/or homo-oligomers that affect DNA-
binding specificity, affinity for promoter elements, and nuclear localization (Vinson 
et al., 2006; Husberg et al., 2003). Heterodimerization has been reported in various 
human bZIP TF families, including Fos/Jun, ATF/CREB, and C/EBP (Cao et al., 
1991; Smeal et al., 1989; Karpinski et al., 1992). Fos/Jun heterodimers have higher 
DNA-binding activity than Jun homodimers (Smeal et al., 1989). ATF-1/CREB 
heterodimers activate transcription for different periods compared to ATF-1 
homodimers (Karpinski et al., 1992; Kobayashi and Kawakami, 1995). Common 
plant regulatory protein 1 (CPRF1), a bZIP TF in parsley that has been implicated 
in light-responsive element-mediated mechanisms, selectively forms heterodimers 
with CPRF4a (Kircher et al., 1998). Class III homeodomain-leucine zipper (HD-
ZIPIII) TFs regulate leaf polarity and vascular development in Arabidopsis 
thaliana and interact with LITTLE ZIPPER (ZPR) proteins as competitive 
inhibitors, resulting in the formation of nonfunctional heterodimers (Wenkel et al., 
2007). Little is known about bZIP TF heterodimerization in fungi. The yeast bZIP 
TFs Met4 and Met28 regulate the sulfur amino acid pathway to produce 
heterodimeric protein complexes (Newman and Keating, 2003). In A. nidulans, 
heterodimerization between bZIP TFs has been detected using an in vitro assay 
(Yin et al., 2013), but the underlying regulatory mechanism remains unclear. 
 In Saccharomyces cerevisiae, one of the best-characterized bZIP TFs is 
GCN4 (Fernandes et al., 1997). GCN4 directly binds to the optimal bZIP binding 
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site (TGAC/GTCA). However, the binding sequence of the other yeast bZIP 
protein, Yap1, differs at two of the five highly conserved residues in its GCN4 
binding sites. Yap1 directly regulates the transcription of the γ-glutamyl cysteine 
synthetase (GSH1), thioredoxin (TRX2), ATP-binding transporter (YCF1), and 
glutathione reductase (GLR1) genes, which are involved in the cellular oxidative 
stress response. The Yap1 recognition site in GSH1 is TGACTAA; this sequence 
differs from the GCN4 binding site by a single base pair. Alternatively those in the 
TRX2, YCF, and GLR1 promoters differ at two positions from the GCN4 binding 
site (TTACTAA). I found a GCN4 motif only in the promoter of ZEB1 (from -177 
to -171) but did not detect the typical consensus bZIP binding sequence in the 
promoter region of PKS4, PKS13, or ZEB2. It appears that ZEB2L may bind to the 
unusual and distinct bZIP binding sites in the promoters of these four cluster genes, 
such as yeast Yap1. Further investigation is necessary to identify the bZIP binding 
sequences in the promoter region of ZEA biosynthetic cluster genes. 
 Fungal secondary metabolites are typically synthesized by genes that are 
grouped into contiguous clusters (Keller et al., 2005). Pathway-specific regulators, 
which are often found in these clusters, positively regulate the expression of 
secondary metabolite biosynthetic pathway genes, such as TRI6 for trichothecenes 
(Proctor et al., 1995), GIP2 for aurofusarin (Kim et al., 2006), and AflR for 
aflatoxin and sterigmatocystin (Woloshuk et al., 1994; Fernandes et al., 1998). 
Most of the potential regulators of fungal polyketide synthase (PKS)-encoding 
cluster genes belong to the zinc cluster family (Brakhage, 2012). ZEB2 is the only 
known bZIP TF that is encoded by a secondary metabolite biosynthetic cluster gene 
and that regulates genes within that cluster in fungi. 
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 bZIP TFs are typically involved in developmental and physiological 
processes and are responsive to environmental stress in eukaryotes (Tian et al., 
2011). In Saccharomyces cerevisiae, bZIP TFs have been implicated in responses 
to oxidative and osmotic stress, DNA damage, amino acid starvation, and 
alternative carbon source utilization (Tan et al., 2008; Workman et al., 2006; Rep et 
al., 2001; Hinnebusch, 2005). In filamentous fungi, bZIP TFs respond to amino 
acid starvation, sulfur sources, oxidative stress, and virulence (Tian et al., 2011; 
Ebbole et al., 1991; Guo et al., 2011). The association between bZIP proteins and 
secondary metabolite biosynthesis was recently proposed as a novel function of 
bZIP TFs in filamentous fungi. The overexpression of the A. nidulans Yap-like 
bZIP RsmA increased sterigmatocystin production by activating the zinc-finger TF 
AflR (Yin et al., 2013). Moreover, F. graminearum FgAP1 mediates trichothecene 
biosynthesis (Montibus et al., 2013), and A. fumigatus FlbB is required for 
gliotoxin production (Xiao et al., 2010). 
 In-depth analyses of TFs in F. graminearum have revealed that several 
bZIP TFs, with the exception of the ZEB2 gene, affect ZEA production (Son et al., 
2011b). However, most of the characterized fungal bZIP TFs are not located in a 
contiguous cluster and do not directly activate secondary metabolite biosynthetic 
cluster genes. In A. fumigatus, FlbB encodes two bZIP domain proteins from a 
single gene, in contrast to A. nidulans (Xiao et al., 2010). These two proteins are 
hypothesized to be induced by the alternative initiation of transcripts in a process 
similar to that for ZEB2; however, the underlying regulatory mechanism has not 
been determined. 
 In conclusion, ZEB2L forms heterodimers in vivo with the truncated 
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isoform ZEB2S, resulting in the autoregulation of ZEA biosynthesis via the 
attenuation of activator gene transcription. This study is the first to demonstrate the 
functional roles of bZIP TF heterodimers in secondary metabolite biosynthesis in a 
eukaryotic microorganism. I propose a novel regulatory mechanism that is self-
controlled by fungal alternative isoforms, similar to the mechanisms observed in 
higher eukaryotes. These findings provide mechanistic insights into the regulation 
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Fusarium graminearum의 ZEB2 
동형단백질에 의한 지랄레논 생합성 
자가조절 연구 
 
박    애    란 
 
초    록 
 
자낭균인 붉은곰팡이(Fusarium graminearum)는 전세계적으로 주요 곡류에 
막대한 경제적 손실을 일으키는 이삭마름병의 원인균이다. 지랄레논
(zearalenone)은 붉은곰팡이가 생산하는 폴리케티드 곰팡이독소로서 인축
에 생식능력저하 등의 과에스트로겐 증상을 보이는 중독현상을 유발한다. 
지랄레논의 생합성은 붉은곰팡이 내에서 몇몇의 인접한 유전자 군에 의
해 이루어지는데, 환원 폴리케티드 생성효소, 비환원 폴리케티드 생성효
소, 이소아밀 알코올 산화효소, basic leucine zipper (bZIP) 전사조절인자 단
백질을 각각 암호화하는 PKS4, PKS13, ZEB1, ZEB2 유전자가 그 안에 포
함되어 있다. 본 연구에서는 지랄레논 생합성 유전자 군의 전사를 조절
하는 핵심유전자 ZEB2의 기능과 그로 인한 지랄레논 생합성 조절기작을 
연구하였다. 그 결과 ZEB2는 alternative promoter의 조절을 통해 두 개의 
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ZEB2 동형단백질(ZEB2L과 ZEB2S)을 생산하며 이들이 지랄레논 생합성 
조절에 관여함을 발견하였다. ZEB2S는 bZIP DNA 결합부위가 존재하는 
ZEB2L단백질의 아미노기 말단이 완전히 절단된 동형단백질로, ZEB2L과 
헤테로다이머를 형성하고 ZEB2L 전사를 촉진하는 ZEB2L 호모다이머의 
프로모터 결합을 방해하여 ZEB2L의 전사조절인자로서의 기능을 저해함
을 밝혀냈다. 또한 붉은곰팡이 세포내의 지랄레논이 ZEB2L과 ZEB2S의 
전사를 유도하여 ZEB2 발현자가조절에 관여하며 이를 통하여 지랄레논
의 생합성에 영향을 줄 수 있음을 확인하였다. 이 연구는 alternative 
promoter에 의해 발현된 ZEB2 동형단백질의 서로 다른 기능과 지랄레논
의 상호작용에 의한 F. graminearum ZEB2 발현의 자가조절과 그로 인한 
지랄레논 생합성의 피드백 루프 조절기작을 설명하고 있으며 이는 전사
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